Literature DB >> 21918465

High-performance work systems in health care, part 3: the role of the business case.

Paula H Song1, Julie Robbins, Andrew N Garman, Ann Scheck McAlearney.   

Abstract

BACKGROUND: Growing evidence suggests the systematic use of high-performance work practices (HPWPs), or evidence-based management practices, holds promise to improve organizational performance, including improved quality and efficiency, in health care organizations. However, little is understood about the investment required for HPWP implementation, nor the business case for HPWP investment.
PURPOSE: The aim of this study is to enhance our understanding about organizations' perspectives of the business case for HPWP investment, including reasons for and approaches to evaluating that investment. METHODOLOGY/APPROACH: We used a multicase study approach to explore the business case for HPWPs in U.S. health care organizations. We conducted semistructured interviews with 67 key informants across five sites. All interviews were recorded, transcribed, and subjected to qualitative analysis using both deductive and inductive methods.
FINDINGS: The organizations in our study did not appear to have explicit financial return expectations for investments in HPWPs. Instead, the HPWP investment was viewed as an important factor contributing to successful execution of the organization's strategic priorities and a means for competitive differentiation in the market. Informants' characterizations of the HPWP investment did not involve financial terms; rather, descriptions of these investments as redeployment of existing resources or a shift of managerial time redirected attention from cost considerations. Evaluation efforts were rare, with organizations using broad organizational metrics to justify HPWP investment or avoiding formal evaluation altogether. PRACTICE IMPLICATIONS: Our findings are consistent with prior studies that have found that health care organizations have not systematically evaluated the financial outcomes of their quality-related initiatives or tend to forget formal business case analysis for investments they may perceive as "inevitable." In the absence of a clearly described association between HPWPs and outcomes or some other external imperative, ongoing HPWP investment may be at risk relative to other quality-related initiatives, particularly if organizational resources are constrained.

Mesh:

Year:  2012        PMID: 21918465     DOI: 10.1097/HMR.0b013e31822e2a6b

Source DB:  PubMed          Journal:  Health Care Manage Rev        ISSN: 0361-6274


  3 in total

1.  The business case for provider participation in clinical trials research: an application to the National Cancer Institute's community clinical oncology program.

Authors:  Paula H Song; Kristin L Reiter; Bryan J Weiner; Lori Minasian; Ann Scheck McAlearney
Journal:  Health Care Manage Rev       Date:  2013 Oct-Dec

2.  Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program.

Authors:  Ann Scheck McAlearney; Paula H Song; Kristin L Reiter
Journal:  Contemp Clin Trials       Date:  2012-08-19       Impact factor: 2.226

Review 3.  The Nursing Leadership Institute program evaluation: a critique.

Authors:  Farinaz Havaei; Maura MacPhee
Journal:  J Healthc Leadersh       Date:  2015-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.